Browsing Working papers (SNF) by Author "Holmås, Tor Helge"

Now showing items 1-10 of 10

    • Bør kommuner kjøpe helseforsikring 

      Askildsen, Jan Erik; Holmås, Tor Helge; Nordanger, Lene Kristin (Arbeidsnotat, Working paper, 2006-12)
      Private helseforsikringer har så langt hatt et relativt beskjedent omfang i Norge, også sammenliknet med våre skandinaviske naboland. Den viktigste årsaken til at relativt få tegner private forsikringer mot sykdom, er ...

    • Competition and physician behaviour: Does the competitive environment affect the propensity to issue sickness certificates? 

      Straume, Odd Rune; Brekke, Kurt R.; Holmås, Tor Helge; Monstad, Karin (Working paper, 2018-09)
      Competition among physicians is widespread, but compelling empirical evidence on its impact on service provision is limited, mainly due to endogeneity issues. In this paper we exploit that many GPs, in addition to own ...

    • Eldre sykehuspasienter og det kommunale pleie- og omsorgstilbudet 

      Holmås, Tor Helge; Kjerstad, Egil; Kristiansen, Frode; Lurås, Hilde (Arbeidsnotat, Working paper, 2007-03)
      Dette notatet dokumenter resultater fra ett av flere arbeider som hadde som formål å evaluere effekter av sykehusreformen. Målet med reformen, som ble gjennomført fra 1. januar 2002, var å legge grunnlaget for en helhetlig ...

    • How does the type of remuneration affect physician behaviour? Fixed salary versus fee-for-service 

      Brekke, Kurt R.; Holmås, Tor Helge; Monstad, Karin; Straume, Odd Rune (Working paper, 2018-09)
      We analyse the effects of fee-for-service versus fixed salary on the treatment decisions of general practitioners (GPs) and on patients’ health outcomes. Using rich Norwegian register data during 2009-2013, we find that ...

    • Is there a demand response by patients in primary care? 

      Holmås, Tor Helge; Kaarbøe, Oddvar M. (Working paper, Working paper, 2006-11)
      We test whether a demand response by patients exists in the Norwegian primary care sector. In Norway, physicians are remunerated either by salary or by incentive contract, and we have access to a large data survey that ...

    • Long term care and hospital length of stay for elderly patients 

      Holmås, Tor Helge; Kjerstad, Egil; Kristiansen, Frode; Lurås, Hilde (Working paper, Working paper, 2007-04)
      The proportion of elderly people in the population is increasing and old patients’ bed occupancy rate in hospitals increases as a fraction of total bed occupancy. Because old patients, on average, are frailer than other ...

    • A low-key social insurance reform : treatment effects for back pain patients in Norway 

      Aakvik, Arild; Holmås, Tor Helge; Kjerstad, Egil (Working Paper, Working paper, 2002-04)
      This paper estimates treatment effects for back pain patients using observational data from a low-key insurance reform in Norway. Using a latent variable model we estimate the average treatment effects (ATE), the average ...

    • Margins and market shares : pharmacy incentives for generic substitution 

      Brekke, Kurt Richard; Holmås, Tor Helge; Straume, Odd Rune (Working paper;08/13, Working paper, 2013-02)
      We study the impact of product margins on pharmacies’ incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to ...

    • Prioriteringspraksis før og etter sykehusreformen 

      Askildsen, Jan Erik; Holmås, Tor Helge; Kaarbøe, Oddvar M. (Arbeidsnotat, Working paper, 2007-03)
      Dette notatet dokumenter resultater fra ett av flere arbeider som hadde som formål å evaluere effekter av sykehusreformen. Målet med reformen, som ble gjennomført fra 1. januar 2002, var å legge grunnlaget for en helhetlig ...

    • Regulation and pricing of pharmaceuticals : reference pricing or price cap regulation? 

      Brekke, Kurt Richard; Grasdal, Astrid Louise; Holmås, Tor Helge (Working paper, Working paper, 2006-11)
      We study the relationship between regulatory regimes and pharmaceutical firms pricing strategies using a unique policy experiment from Norway, which in 2003 introduced a reference price (RP) system called “index pricing” ...